Bodenrader Mark 4

4 · Cerevel Therapeutics Holdings, Inc. · Filed Jun 3, 2022

Insider Transaction Report

Form 4
Period: 2022-06-01
Bodenrader Mark
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2022-06-01+18,93218,932 total
    Common Stock (18,932 underlying)
Footnotes (2)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
  • [F2]25% of the RSUs shall vest on each of the first, second, third and fourth anniversary of June 1, 2022, subject to the Reporting Person's continued service relationship with the Issuer through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION